SEC Filing Details
Document Details
Form
Filing Date
February 27, 2023
Document Date
February 23, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Schwab Andrew J.